T cells are just dying to accept grafts

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1231-1232

  Ferguson, Thomas A ^a   Green, Douglas R ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYCLOSPORIN A; FAS LIGAND; INTERLEUKIN 10; RAPAMYCIN;

ALLOIMMUNITY; ANTIGEN PRESENTATION; APOPTOSIS; CELL DEATH; CYTOKINE RELEASE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

APOPTOSIS; GRAFT SURVIVAL; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 0032719064     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15180     Document Type: Short Survey

References (13)

1. Lenardo, M. et al. Mature T lymphocyte apoptosis-Immune regulation in a dynamic and unpredictable antigenic environment. Ann. Rev. Immunol. 17, 221-253 (1999).
2. Griffith, T.S. et al. Fas-Ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1191 (1995).
3. Stuart, P.M. et al. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest. 99, 396-402 (1997).
4. Li, Y. et al. Global immunosuppression prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nature Med. 5, 1298-1302 (1999).
5. Wells, A.D. et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nature Med. 5 1 303-1 307 (1999).
6. Larsen, C.P. et al. Long term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996).
7. Kirk, A.D. et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med. 5, 686-693 (1999).
8. Brunner, T. et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444 (1995).
9. Li, X.C. et al. Induction of allograft tolerance in the absence of Fas-mediated apoptosis. J. Immunol. 163, 2500-2507 (1999).
10. Griffith, T.S. et al. CD95-ligand induced apoptosis of lymphocytes in an immune privileged site induces immunologic tolerance. Immunity, 5, 7-16 (1996).
11. Gao, Y. et al. The anti-inflammatory effects of CD95 ligand (FasL) induced apoptosis. J. Exp. Med. 188, 887-896 (1998).
12. Fadok V.A. et al. Macrophages that have ingested apoptotic cell in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TCF-beta, PGE2, and PAF. J. Clin. Invest. 101, 890-898 (1999).
13. Ronchetti, A. et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, APC and cytokines. J. Immunol. 163, 130-136 (1999).